The plant in Horsovsky Tyn manufactures inhalers, insulin pens, lancing devices and various diagnostic systems.
Gerresheimer, headquartered in Düsseldorf, plans to double the production area at the facility to around 10,400m2 and increase the workforce from 375 to approximately 450.
Gerresheimer’s chief executive Uwe Röhrhoff said as the treatment of illnesses such as diabetes and asthma becomes more widespread, so the company aims to grow its market share of medical plastic systems for diagnostics and the application of drugs to treat them.
‘Our Czech plant will play a crucial role in this process because it’s one of our most modern medical plastic systems production facilities,’ he said.
The extension is due to be completed before the end of 2011.
Gerresheimer’s Plastic Systems division is now one of the company’s fastest-growing divisions. Gerresheimer Medical Plastic Systems produces insulin pens for diabetics, inhalers for asthma sufferers, lancing devices and laboratory disposables.
